576 related articles for article (PubMed ID: 23049765)
1. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
[TBL] [Abstract][Full Text] [Related]
3. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
[No Abstract] [Full Text] [Related]
4. Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.
Stokell JR; Gharaibeh RZ; Hamp TJ; Zapata MJ; Fodor AA; Steck TR
J Clin Microbiol; 2015 Jan; 53(1):237-47. PubMed ID: 25392361
[TBL] [Abstract][Full Text] [Related]
5. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
Nguyen LD; Deschaght P; Merlin S; Loywick A; Audebert C; Van Daele S; Viscogliosi E; Vaneechoutte M; Delhaes L
PLoS One; 2016; 11(12):e0168860. PubMed ID: 28030619
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
Conway SP; Brownlee KG; Denton M; Peckham DG
Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
[TBL] [Abstract][Full Text] [Related]
7. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
8. Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.
Stressmann FA; Rogers GB; van der Gast CJ; Marsh P; Vermeer LS; Carroll MP; Hoffman L; Daniels TW; Patel N; Forbes B; Bruce KD
Thorax; 2012 Oct; 67(10):867-73. PubMed ID: 22707521
[TBL] [Abstract][Full Text] [Related]
9. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
[TBL] [Abstract][Full Text] [Related]
10. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
[TBL] [Abstract][Full Text] [Related]
11. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
Delhaes L; Monchy S; Fréalle E; Hubans C; Salleron J; Leroy S; Prevotat A; Wallet F; Wallaert B; Dei-Cas E; Sime-Ngando T; Chabé M; Viscogliosi E
PLoS One; 2012; 7(4):e36313. PubMed ID: 22558432
[TBL] [Abstract][Full Text] [Related]
12. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.
Twomey KB; Alston M; An SQ; O'Connell OJ; McCarthy Y; Swarbreck D; Febrer M; Dow JM; Plant BJ; Ryan RP
PLoS One; 2013; 8(12):e82432. PubMed ID: 24358183
[TBL] [Abstract][Full Text] [Related]
13. Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention.
Cuthbertson L; Rogers GB; Walker AW; Oliver A; Green LE; Daniels TW; Carroll MP; Parkhill J; Bruce KD; van der Gast CJ
ISME J; 2016 May; 10(5):1081-91. PubMed ID: 26555248
[TBL] [Abstract][Full Text] [Related]
14. Decade-long bacterial community dynamics in cystic fibrosis airways.
Zhao J; Schloss PD; Kalikin LM; Carmody LA; Foster BK; Petrosino JF; Cavalcoli JD; VanDevanter DR; Murray S; Li JZ; Young VB; LiPuma JJ
Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5809-14. PubMed ID: 22451929
[TBL] [Abstract][Full Text] [Related]
15. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation.
Carmody LA; Zhao J; Schloss PD; Petrosino JF; Murray S; Young VB; Li JZ; LiPuma JJ
Ann Am Thorac Soc; 2013 Jun; 10(3):179-87. PubMed ID: 23802813
[TBL] [Abstract][Full Text] [Related]
16. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
[TBL] [Abstract][Full Text] [Related]
17. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
[TBL] [Abstract][Full Text] [Related]
18. Lung function and microbiota diversity in cystic fibrosis.
Cuthbertson L; Walker AW; Oliver AE; Rogers GB; Rivett DW; Hampton TH; Ashare A; Elborn JS; De Soyza A; Carroll MP; Hoffman LR; Lanyon C; Moskowitz SM; O'Toole GA; Parkhill J; Planet PJ; Teneback CC; Tunney MM; Zuckerman JB; Bruce KD; van der Gast CJ
Microbiome; 2020 Apr; 8(1):45. PubMed ID: 32238195
[TBL] [Abstract][Full Text] [Related]
19. Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.
Tunney MM; Einarsson GG; Wei L; Drain M; Klem ER; Cardwell C; Ennis M; Boucher RC; Wolfgang MC; Elborn JS
Am J Respir Crit Care Med; 2013 May; 187(10):1118-26. PubMed ID: 23348972
[TBL] [Abstract][Full Text] [Related]
20. Changes in airway bacterial communities occur soon after initiation of antibiotic treatment of pulmonary exacerbations in cystic fibrosis.
Carmody LA; Kalikin LM; VanDevanter DR; Li G; Opron K; Simon RH; Caverly LJ; LiPuma JJ
J Cyst Fibros; 2022 Sep; 21(5):766-768. PubMed ID: 35667975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]